Lakewood Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-678,917
Closed -$15.5M – 48
2022
Q1
$15.5M Sell
678,917
-97,700
-13% -$2.39M 0.78% 35
2021
Q4
$21.4M Hold
776,617
– – 0.91% 35
2021
Q3
$21.6M Sell
776,617
-40,000
-5% -$1.13M 0.95% 32
2021
Q2
$23.9M Sell
816,617
-10,000
-1% -$303K 0.99% 31
2021
Q1
$26.2M Sell
826,617
-586,200
-41% -$17.2M 1.11% 31
2020
Q4
$29.4M Hold
1,412,817
– – 1.38% 27
2020
Q3
$22M Buy
1,412,817
+25,000
+2% +$431K 1.06% 32
2020
Q2
$25.4M Buy
1,387,817
+712,472
+105% +$12.6M 1.09% 32
2020
Q1
$10.5M Hold
675,345
– – 0.48% 36
2019
Q4
$20.2M Buy
+675,345
New +$17.6M 0.71% 30
2016
Q4
– Sell
-391,000
Closed -$9.6M – 39
2016
Q3
$9.6M Buy
+391,000
New +$10.1M 0.22% 37

Other funds holding BHC

Lakewood Capital Management's BHC Position: Q2 2022 in Review

Lakewood Capital Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 678,917 shares — an estimated $15.5M sold.

Lakewood Capital Management first reported a position in BHC in Q3 2016 and held it in 11 quarters. The position peaked at $29.4M in Q4 2020. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Lakewood Capital Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Lakewood Capital Management sold 678,917 Bausch Health shares in Q2 2022, an estimated $15.5M.
  • Lakewood Capital Management first reported a position in Bausch Health in Q3 2016 and held it in 11 quarters.
  • Lakewood Capital Management's Bausch Health position peaked at $29.4M in Q4 2020.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Lakewood Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.